|
(V529) |
Inhibition of mitochondrial benzodiazepine receptor protects cardiomyocytes against acute reoxygenation injury |
| |
|
V. Johnson, W. Iraqi, O. Dörr, C. Troidl, H. M. Nef, C. W. Hamm, Y. Abdallah (Gießen, Münster) |
|
|
Diskussion |
|
(V530) |
Mitochondrial metabolism is altered via IP3-mediated Ca release. |
| |
|
L. Seidlmayer, J. Kuhn, O. Ritter (Würzburg) |
|
|
Diskussion |
|
(V531) |
Moderate SirT1 overexpression protects against high fat diet induced impaired glucose tolerance and mitochondrial dysfunction |
| |
|
A. Schrepper, M. Schwarzer, T. Doenst (Jena) |
|
|
Diskussion |
|
(V532) |
SIRT3 Deficiency impairs Mitochondrial and Contractile Function in the Heart |
| |
|
C. Koentges, K. Pfeil, T. Schnick, S. Wiese, C. Jäger, B. Kammerer, L. Hein, C. Bode, H. Bugger (Freiburg im Breisgau) |
|
|
Diskussion |
|
(V533) |
Mitochondrial protection with the antioxidative peptide SS-31 prevents necrosis, apoptosis and mortality but not fibriosis after pressure overload |
| |
|
A. Nickel, M. Stadelmaier, J.-C. Reil, M. Kohlhaas, M. Böhm, C. Maack (Homburg/Saar) |
|
|
Diskussion |
|
(V534) |
Deficiency of MAP-kinase-activated protein kinase 2 (MK2) targeting mitochondrial oxidative stress protects against aging-induced cardiac remodeling and dysfunction |
| |
|
P. R. Kapopara, D. Fraccarollo, M. Kasten, M. Korf-Klingebiel, P. Galuppo, S. Pretzer, K. C. Wollert, M. Gaestel, J. Bauersachs, U. Bavendiek (Hannover) |
|
|
Diskussion |